Target intelligence / Profile preview

T cell tolerance induction via allergen presentation (None)

Target
None
Molecular classification
Immune process, Cellular communication, Antigen presentation
01

Overview

T cell tolerance induction via allergen presentation refers to the process by which the immune system becomes non-responsive or tolerant to specific allergens, preventing allergic reactions. This is achieved through the presentation of allergenic antigens by antigen-presenting cells (APCs) such as dendritic cells (DCs), B cells, and macrophages, which direct T cell differentiation toward regulatory phenotypes rather than pro-allergic effector types. Key mechanisms involve APC subsets like cDC1s and Rorγt+ APCs promoting regulatory T cell (pTreg) induction and cytokines such as IL-10 and TGF-β mediating suppression of allergic inflammation. This process is crucial for maintaining oral/respiratory tolerance and preventing IgE-mediated allergies and is the basis for allergen immunotherapy.

02

Mechanism of action

Promotes deletion of pathogenic Th2(a) populations and/or expansion/activation of regulatory populations like Tr1/Treg cells.

03

Biological functions

Immune toleranceT cell differentiationAntigen presentationRegulation of immune responseCytokine production
04

Disease associations

AllergyAutoimmunity
05

Safety considerations

Risk of anaphylaxis during allergen immunotherapyPotential for immune suppression
06

Interacting drugs

Allergen immunotherapy

1 more in the full profile.

07

Biomarkers

Foxp3 expressionIL-10 productionTGF-β productionAllergen-specific IgE levelsTh2 cytokine levels

Beyond the preview

Go deeper on T cell tolerance induction via allergen presentation (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell tolerance induction via allergen presentation (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call